Skip to content

BBNX BBNX Net Change in Cash

Net Change in Cash at other companies

Insulet logo
InsuletPODD
-$235.7M-171%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$88.69M+666%
Medtronic logo
MedtronicMDT
-$136M+11.7%
AdaptHealth logo
AdaptHealthAHCO
-$58.17M-3.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$175.59M+190%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's net change in cash?
BBNX (BBNX) reported net change in cash of -$1.37M in Q1 2026.
How has BBNX's net change in cash changed year-over-year?
BBNX's net change in cash decreased by 111.4% year-over-year, from $12.02M to -$1.37M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.